Financings roundup: SBi raises $108M 'D' round; Lumenis gets $15 million
At a time when medical device companies are struggling to keep afloat it is refreshing to see there are still some companies out there that have managed to bring in some significant cash. (Medical Device Daily)
The BB&T interview: Hans Hofstraat, Vice president, Philips Research
While competitors rapidly buy their way into the breaking new field of molecular medicine, Philips Healthcare is pursing what might be called a green-field approach to the market, seeking to build new technologies from the ground up and to discover novel biomarkers from scratch. While it seems to be a strategy in keeping with the company's slogan of 'Sense and Simplicity,' Philips could instead be seen as taking a cautious approach to what is a promising but unproven opportunity. (Biomedical Business & Technology)
There's no Expiration on this Knowledge, but the Education Opportunity will Expire July 31!
Catch up on what you've missed for 40% off! This is your opportunity to get in the know and listen to noted speakers in the industry discuss current topics affecting your business today. BioWorld Today and Medical Device Daily offers this special rate through July 31, 2009. Click here and order now!
Exosome, DxS collaborating on blood-based cancer tests
The days of cutting out cancerous tissue to examine under a microscope for a firm diagnosis may be numbered. By next year, Exosome Diagnostics (New York) expects to have blood-based cancer diagnostics on the market. (Diagnostics & Imaging Week)
